Concepedia

Publication | Closed Access

PRECLINICAL AND PHASE 1 CLINICAL SAFETY OF SETARUD (IMODTM), A NOVEL IMMUNOMODULATOR

20

Citations

19

References

2009

Year

References

YearCitations

Page 1